Publication | Closed Access
Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial
53
Citations
39
References
2019
Year
New DrugAutoimmune DiseaseImmunologyClinical TrialsPharmacotherapyRif PatientsMedicineElevated Th17/treg Ratio
| Year | Citations | |
|---|---|---|
Page 1
Page 1